1973
DOI: 10.1016/s0021-9258(19)43380-2
|View full text |Cite
|
Sign up to set email alerts
|

Sequence of Tryptic Cleavages in Porcine Pancreatic Secretory Inhibitor II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1974
1974
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…The heterogeneous ligand model has been previously used for the Kazal inhibitor SPINK9 [40] and represents a linear combination of two 1:1 L binding models describing two independent binding sites of the ligand. Since SPINK1 can exist in two states after complex formation with trypsin (one with an intact K41-I42 bond and one with a cleaved K41-I42) [41] it is reasonable to assume that the uncleaved and the cleaved* species display different kinetic properties. Consistent with other trypsin inhibitors [42], SPINK1 reveals a lower K D1 , whereas the second set of parameters refers to SPINK1* showing an increased K D2 , indicating a decreased binding affinity for the cleaved species.…”
Section: Discussionmentioning
confidence: 99%
“…The heterogeneous ligand model has been previously used for the Kazal inhibitor SPINK9 [40] and represents a linear combination of two 1:1 L binding models describing two independent binding sites of the ligand. Since SPINK1 can exist in two states after complex formation with trypsin (one with an intact K41-I42 bond and one with a cleaved K41-I42) [41] it is reasonable to assume that the uncleaved and the cleaved* species display different kinetic properties. Consistent with other trypsin inhibitors [42], SPINK1 reveals a lower K D1 , whereas the second set of parameters refers to SPINK1* showing an increased K D2 , indicating a decreased binding affinity for the cleaved species.…”
Section: Discussionmentioning
confidence: 99%
“…SPINK1 is a so-called temporary inhibitor as it becomes inactivated over time and releases the active protease (28). This process starts with the cleavage of the SPINK1 reactive-site peptide bond by the bound trypsin followed by inactivating cleavages at Arg67-Gln68 and elsewhere by excess trypsin (20,(29)(30)(31). We compared the release of nonsulfated and sulfated human cationic trypsin from SPINK1 complexes and found that sulfated trypsin was released at a significantly higher rate than nonsulfated trypsin (Fig.…”
Section: Temporary Inhibition By Wildtype Spink1 and The N34s Mutantmentioning
confidence: 99%